Lloyd-Jones D, Adams R, Carnethon M, et al. Heart disease and stroke statistics - 2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2009;119:e21–e181.
PubMed
Article
Google Scholar
Banach M, Aronow WS. Hypertension therapy in the older adults-do we know the answers to all the questions? The status after publication of the ACCF/AHA 2011 expert consensus document on hypertension in the elderly. J Hum Hypertens 2012; DOI: 10.1038/jhh.2012.3.
Chockalingam A, Campbell NR, Fodor JG. Worldwide epidemic of hypertension. Can J Cardiol. 2006;22:553–5.
PubMed
Article
Google Scholar
Bielecka-Dabrowa A, Aronow WS, Rysz J, Banach M. The Rise and Fall of Hypertension: Lessons Learned from Eastern Europe. Curr Cardiovasc Risk Rep. 2011;5:174–9.
PubMed
Article
Google Scholar
Barylski M, Małyszko J, Rysz J, Myśliwiec M, Banach M. Lipids, blood pressure, kidney—what was new in 2011? Arch Med Sci. 2011;7(6):1055–66.
PubMed
Article
Google Scholar
Mancia G, Laurent S, Agabiti-Rosei E, Ambrosioni E, Burnier M, Caulfield MJ, Cifkova R, Clément D, Coca A, Dominiczak A, Erdine S, Fagard R, Farsang C, Grassi G, Haller H, Heagerty A, Kjeldsen SE, Kiowski W, Mallion JM, Manolis A, Narkiewicz K, Nilsson P, Olsen MH, Rahn KH, Redon J, Rodicio J, Ruilope L, Schmieder RE, Struijker-Boudier HA, Van Zwieten PA, Viigimaa M, Zanchetti A. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J Hypertens. 2009;27:2121–58.
PubMed
Article
CAS
Google Scholar
Banach M, Kjeldsen SE, Narkiewicz K. Editorial. Controversies in hypertension treatment. Curr Vasc Pharmacol. 2010;8:731–2.
PubMed
Article
CAS
Google Scholar
Messerli FH, Mancia G, Conti CR, Hewkin AC, Kupfer S, Champion A, Kolloch R, Benetos A, Pepine CJ. Dogma disputed: can aggressively lowering blood pressure in hypertensive patients with coronary artery disease be dangerous? Ann Intern Med. 2006;144:884–93.
PubMed
Google Scholar
Reboldi G, Gentile G, Manfreda VM, Angeli F, Verdecchia P. Tight blood pressure control in diabetes: evidence-based review of treatment targets in patients with diabetes. Curr Cardiol Rep. 2012;14:89–96.
PubMed
Article
Google Scholar
Banach M, Michalska M, Kjeldsen SE, Małyszko J, Mikhailidis DP, Rysz J. What should be the optimal levels of blood pressure: Does the J-curve phenomenon really exist? Expert Opin Pharmacother. 2011;12(12):1835–44.
PubMed
Article
Google Scholar
Gluba A, Bielecka A, Mikhailidis DP, Wong ND, Franklin SS, Rysz J, Banach M. An update on biomarkers of heart failure in hypertensive patients. J Hypertens. 2012;30:1681–9.
PubMed
Article
CAS
Google Scholar
Kaplan NM. The diastolic J curve: alive and threatening. Hypertension. 2011;58(5):751–3.
PubMed
Article
CAS
Google Scholar
Panjrath GS, Chaudhari S, Messerli FH. The J-point phenomenon in aggressive therapy of hypertension: new insights. Curr Atheroscler Rep. 2012;14(2):124–9.
PubMed
Article
CAS
Google Scholar
Stewart IM. Relation of reduction in pressure to first myocardial infarction in patients receiving treatment for severe hypertension. Lancet. 1979;1:861–5.
PubMed
Article
CAS
Google Scholar
Cruickshank JM, Thorp JM, Zacharias FJ. Benefits and potential harm of lowering high blood pressure. Lancet. 1987;1(8533):581–4.
PubMed
Article
CAS
Google Scholar
D'Agostino RB, Belanger AJ, Kannel WB, Cruickshank JM. Relation of low diastolic blood pressure to coronary heart disease death in presence of myocardial infarction: the Framingham Study. BMJ. 1991;303:385–9.
PubMed
Article
Google Scholar
Dudenbostel T, Oparil S. J curve in hypertension. Curr Cardiovasc Risk Rep. 2012;6:281–90.
Article
Google Scholar
Polese A, De Cesare N, Montorsi P, Fabbiocchi F, Guazzi M, Loaldi A, Guazzi MD. Upward shift of the lower range of coronary flow autoregulation in hypertensive patients with hypertrophy of the left ventricle. Circulation. 1991;83:845–53.
PubMed
Article
CAS
Google Scholar
Okoński P, Banach M, Rysz J, Barylski M, Irzmański R, Piechota M, Zasłonka J. L-arginine improves hemodynamic function and coronary flow in an experimental model of ischemia-reperfusion injury. Ann Transplant. 2006;11(1):28–34.
PubMed
Google Scholar
Ma J, Qian J, Ge J, Zeng X, Sun A, Chang S, Chen Z, Zou Y. Changes in left ventricular ejection fraction and coronary flow reserve after coronary microembolization. Arch Med Sci. 2012;8(1):63–9.
PubMed
Article
Google Scholar
Williams B, Lindholm LH, Sever P. Systolic pressure is all that matters. Lancet. 2008;371:2219–21.
PubMed
Article
Google Scholar
Zanchetti A, Grassi G, Mancia G. When should antihypertensive drug treatment be initiated and to what levels should systolic blood pressure be lowered? A critical appraisal. J Hypertens. 2009;27:923–34.
PubMed
Article
CAS
Google Scholar
Marschner IC, Simes RJ, Keech A. Biases in the identification of risk factor thresholds and J-curves. Am J Epidemiol. 2007;166:824–31.
PubMed
Article
Google Scholar
Kalantar-Zadeh K, Block G, Horwich T, Fonarow G. Reverse epidemiology of conventional cardiovascular risk factors in patients with chronic heart failure. J Am Coll Cardiol. 2004;43:1439–44.
PubMed
Article
Google Scholar
Sarwar N, Gao P, Seshasai SR, Gobin R, Kaptoge S, DiAngelantonio E, et al. Emerging Risk Factors Collaboration. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet. 2010;375:2215–22.
PubMed
Article
CAS
Google Scholar
Hansson L for the BBB Study Group. The BBB Study: The effect of intensified antihypertensive treatment on the level of blood pressure, side effects, morbidity and mortality in “well-treated” hypertensive patients. Blood Press. 1994;3:248–54.
Article
Google Scholar
Hansson L, Zanchetti A, Carruthers SG, Dahlöf B, Elmfeldt D, Julius S, Ménard J, Rahn KH, Wedel H, Westerling S. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet. 1998;351(9118):1755–62.
PubMed
Article
CAS
Google Scholar
Cruickshank JM. Hypertension Optimal Treatment (HOT) trial. Lancet. 1998;352:573–4.
PubMed
Article
CAS
Google Scholar
Hedner T, Oparil S, Narkiewicz K, Kjeldsen SE. The J-curve phenomenon revisited. Blood Press. 2009;18:168–70.
PubMed
Article
Google Scholar
Julius S, Kjeldsen SE, Weber M, Brunner HR, Ekman S, Hansson L, Hua T, Laragh J, McInnes GT, Mitchell L, Plat F, Schork A, Smith B, Zanchetti A. VALUE trial group. Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial. Lancet. 2004;363:2022–3.
PubMed
Article
CAS
Google Scholar
Messerli FH, Mancia G, Weber MA, Kjeldsen SE, Holzhauer B, Hua TA, et al. Low blood pressure is associated with increased cardiovascular morbidity (J-shaped curve) in treated hypertensive patients with increased cardiovascular risk: The VALUE Randomized Trial. J Am Coll Cardiol. 2009;53(Suppl A):A46.
Google Scholar
Sleight P, Redon J, Verdecchia P, Mancia G, Gao P, Fagard R, Schumacher H, Weber M, Böhm M, Williams B, Pogue J, Koon T, Yusuf S. ONTARGET investigators. Prognostic value of blood pressure in patients with high vascular risk in the Ongoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial study. J Hypertens. 2009;27:1360–9.
PubMed
Article
CAS
Google Scholar
Mancia G, Schumacher H, Redon J, Verdecchia P, Schmieder R, Jennings G, et al. Blood pressure targets recommended by guidelines and incidence of cardiovascular and renal events in ONTARGET. Circulation. 2011;124:1727–36.
PubMed
Article
Google Scholar
Banach M, Rysz J. Current problems in hypertension and nephrology. Expert Opin Pharmacother. 2010;11:2575–8.
PubMed
Article
Google Scholar
Verdecchia P, Staessen JA, Angeli F, de Simone G, Achilli A, Ganau A, Mureddu G, Pede S, Maggioni AP, Lucci D, Reboldi G. Cardio-Sis investigators. Usual versus tight control of systolic blood pressure in non-diabetic patients with hypertension (Cardio-Sis): an open-label randomised trial. Lancet. 2009;374:525–33.
PubMed
Article
Google Scholar
Pepine CJ, Handberg EM, Cooper-DeHoff RM, Marks RG, Kowey P, Messerli FH, Mancia G, Cangiano JL, Garcia-Barreto D, Keltai M, Erdine S, Bristol HA, Kolb HR, Bakris GL, Cohen JD, Parmley WW. INVEST Investigators. A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial. JAMA. 2003;290:2805–16.
PubMed
Article
CAS
Google Scholar
Bangalore S, Messerli FH, Wun C, Zuckerman AL, DeMicco D, Kostis JB, LaRosa JC. J-curve revisited: an analysis of the Treating to New Targets (TNT) Trial. J Am Coll Cardiol. 2009;53:A217.
Google Scholar
Bangalore S, Messerli FH, Wun CC, Zuckerman AL, DeMicco D, Kostis JB, LaRosa JC. Treating to New Targets Steering Committee and Investigators. J-curve revisited: An analysis of blood pressure and cardiovascular events in the Treating to New Targets (TNT) Trial. Eur Heart J. 2010;31:2897–908.
PubMed
Article
CAS
Google Scholar
•• Bangalore S, Qin J, Sloan S, Murphy SA, Cannon CP. PROVE IT-TIMI 22 Trial Investigators. What is the optimal blood pressure in patients after acute coronary syndromes?: Relationship of blood pressure and cardiovascular events in the PRavastatin OR atorVastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction (PROVE IT-TIMI) 22 trial. Circulation. 2010;122:2142–51. Very important study in patients with acute coronary syndromes suggesting that low BP, especially <110/70 mmHg, may be very harmful for this group of patients.
PubMed
Article
CAS
Google Scholar
•• Dorresteijn JA, van der Graaf Y, Spiering W, Grobbee DE, Bots ML, Visseren FL. Secondary Manifestations of Arterial Disease Study Group. Relation between blood pressure and vascular events and mortality in patients with manifest vascular disease: J-curve revisited. Hypertension. 2012;59:14–21. One of the most current trials (SMART) in patients with symptomatic vascular disease, which confirmed that a J-curve relationship (increased risk of CV events) was observed above and below the nadir of 143/82 mmHg. A similar nonlinear relationship was also found for DBP and all-cause mortality..
PubMed
Article
CAS
Google Scholar
Bangalore S, Kumar S, Volodarskiy A, Messerli FH. Blood pressure targets in patients with coronary artery disease: observations from traditional and Bayesian random effects meta-analysis of randomised trials. Heart 2012; (in press).
Tryniszewski W, Kuśmierczyk J, Maziarz Z, Goś R, Mikhailidis DP, Banach M, Rysz J, Pesudovs K. Correlation of the severity of diabetic retinopathy and the heart muscle perfusion in patients with type 2 diabetes. J Diabetes Complicat. 2011;25(4):253–7.
PubMed
Article
Google Scholar
•• Cooper-DeHoff RM, Gong Y, Handberg EM, Bavry AA, Denardo SJ, Bakris GL, Pepine CJ. Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease. JAMA. 2010;304:61–8. A retrospective analysis of the INVEST study, which revealed that this risk of CV events was also observed in diabetic patients with SBP below 115 mmHg.
PubMed
Article
CAS
Google Scholar
•• The ACCORD Study Group. Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus. N Engl J Med. 2010;362:1575–85. One of the most anticipated trials, which could have finally confirmed the J-curve relationship in diabetic patients. However, due to some limitations the interpretation of the study is not unequivocal.
Article
Google Scholar
Nilsson PM. ACCORD and risk-factor control in type 2 diabetes. N Engl J Med. 2010;362:1628–30.
PubMed
Article
CAS
Google Scholar
Cooper-DeHoff RM, Egelund EF, Pepine CJ. Blood pressure lowering in patients with diabetes—one level might not fit all. Nat Rev Cardiol. 2011;8:42–9.
PubMed
Article
Google Scholar
Berl T, Hunsicker LG, Lewis JB, Pfeffer MA, Porush JG, Rouleau JL, Drury PL, Esmatjes E, Hricik D, Pohl M, Raz I, Vanhille P, Wiegmann TB, Wolfe BM, Locatelli F, Goldhaber SZ, Lewis EJ, Collaborative Study Group. Impact of achieved blood pressure on cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial. J Am Soc Nephrol. 2005;16:2170–9.
PubMed
Article
CAS
Google Scholar
Schrier RW, Estacio RO, Esler A, Mehler P. Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes. Kidney Int. 2002;61:1086–97.
PubMed
Article
Google Scholar
Redon J, Mancia G, Sleight P, Schumacher H, Gao P, Pogue J, Fagard R, Verdecchia P, Weber M, Böhm M, Williams B, Yusoff K, Teo K, Yusuf S. ONTARGET Investigators. Safety and efficacy of low blood pressures among patients with diabetes: subgroup analyses from the ONTARGET (ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial). J Am Coll Cardiol. 2012;59:74–83.
PubMed
Article
Google Scholar
• Vamos EP, Harris M, Millett C, Pape UJ, Khunti K, Curcin V, Molokhia M, Majeed A. Association of systolic and diastolic blood pressure and all cause mortality in people with newly diagnosed type 2 diabetes: retrospective cohort study. BMJ. 2012;345:e5567. One of the most recent trials investigating the J-shaped relationship in DM patients. Analysing 126,092 adult patients from the United Kingdom General Practice Research Database, it showed that intensive BP lowering (<130/80) was associated with an increased risk of all-cause mortality.
PubMed
Article
Google Scholar
Banach M, Aronow WS. Should we have any doubts about hypertension therapy in elderly patients?: ACCF/AHA 2011 expert consensus document on hypertension in the elderly. Pol Arch Med Wewn. 2011;121:253–7.
Google Scholar
Global Health Risks. Mortality and burden of disease attributable to selected major risks. World Health Organization 2009:
Athyros VG, Giouleme O, Ganotakis ES, Elisaf M, Tziomalos K, Vassiliadis T, Liberopoulos EN, Theocharidou E, Karagiannis A, Mikhailidis DP. Safety and impact on cardiovascular events of long-term multifactorial treatment in patients with metabolic syndrome and abnormal liver function tests: a post hoc analysis of the randomised ATTEMPT study. Arch Med Sci. 2011;7:796–805.
PubMed
Article
CAS
Google Scholar
Aronow WS, Banach M. Ten most important things to learn from the ACCF/AHA 2011 expert consensus document on hypertension in the elderly. Blood Press. 2012;21:3–5.
PubMed
Article
Google Scholar
Vokó Z, Bots ML, Hofman A, Koudstaal PJ, Witteman JC, Breteler MM. J-shaped relation between blood pressure and stroke in treated hypertensives. Hypertension. 1999;34:1181–5.
PubMed
Article
Google Scholar
SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in The Elderly Program. JAMA. 1991;265:3255–64.
Article
Google Scholar
Pastor-Barriuso R, Banegas JR, Damian J, Appel LJ, Guallar E. Systolic blood pressure, diastolic blood pressure, and pulse pressure: an evaluation of their joint effect on mortality. Ann Intern Med. 2003;139:731–9.
PubMed
Google Scholar
Staessen JA, Thijisq L, Fagard R, Celis H, Birkenhäger WH, Bulpitt CJ, de Leeuw PW, Fletcher AE, Forette F, Leonetti G, McCormack P, Nachev C, O'Brien E, Rodicio JL, Rosenfeld J, Sarti C, Tuomilehto J, Webster J, Yodfat Y, Zanchetti A. Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Effects of immediate versus delayed antihypertensive therapy on outcome in the Systolic Hypertension in Europe Trial. J Hypertens. 2004;22:847–57.
PubMed
Article
CAS
Google Scholar
Beckett NS, Peters R, Fletcher AE, et al. Treatment of hypertension in patients 80years of age or older. N Engl J Med. 2008;358:1887–98.
PubMed
Article
CAS
Google Scholar
JATOS Study Group. Principal results of the Japanese trial to assess optimal systolic blood pressure in elderly hypertensive patients (JATOS). Hypertens Res. 2008;31:2115–27.
Article
Google Scholar
Ogihara T, Saruta T, Rakugi H, Matsuoka H, Shimamoto K, Shimada K, Imai Y, Kikuchi K, Ito S, Eto T, Kimura G, Imaizumi T, Takishita S, Ueshima H. Valsartan in Elderly Isolated Systolic Hypertension Study Group. Target blood pressure for treatment of isolated systolic hypertension in the elderly: Valsartan in Elderly Isolated Systolic Hypertension Study. Hypertension. 2010;56:196–202.
PubMed
Article
CAS
Google Scholar
Oates DJ, Berlowitz DR, Glickman ME, Silliman RA, Borzecki AM. Blood pressure and survival in the oldest old. J Am Geriatr Soc. 2007;55(3):383–8.
PubMed
Article
Google Scholar
• Denardo SJ, Gong Y, Nichols WW, et al. Blood pressure and outcomes in very old hypertensive coronary artery disease patients: an INVEST Substudy. Am J Med. 2010;123(8):719–26. A subanalysis of the INVEST trial on 2,180 old (>80 years) participants, which confirmed age-dependent J-shaped relationships between on-treatment SBP (nadir: 110-140 mmHg) and DBP (nadir: 70-75 mmHg) and the primary outcome (all-cause mortality, nonfatal MI or nonfatal stroke).
PubMed
Article
Google Scholar
Ogihara T, Matsuoka H, Rakugi H. Practitioner's trial on the efficacy of antihypertensive treatment in elderly patients with hypertension II (PATE-hypertension II study) in Japan. Geriatr Gerontol Int. 2011;11(4):414–21.
PubMed
Article
Google Scholar
• Okin PM, Hille DA, Kjeldsen SE, Dahlöf B, Devereux RB. Impact of lower achieved blood pressure on outcomes in hypertensive patients. J Hypertens. 2012;30:802–10. A subanalysis of LIFE study, where the authors found that SBP ≤130 mmHg was not associated with lower CV risk (in comparison to the group with SBP of 131 to 141 mmHg) and was associated with a significantly increased (29%) risk of death and a trend towards increased CV mortality.
PubMed
Article
CAS
Google Scholar
• Banach M, Bhatia V, Feller MA, Mujib M, Desai RV, Ahmed MI, Guichard JL, Aban I, Love TE, Aronow WS, White M, Deedwania P, Fonarow G, Ahmed A. Relation of baseline systolic blood pressure and long-term outcomes in ambulatory patients with chronic mild to moderate heart failure. Am J Cardiol. 2011;107:1208–14. This is one of the few studies suggesting a J-shape relationship while lowering SBP below 120 mmHg in patients with chronic heart failure.
PubMed
Article
Google Scholar
Desai RV, Banach M, Ahmed MI, Mujib M, Aban I, Love TE, White M, Fonarow G, Deedwania P, Aronow WS, Ahmed A. Impact of baseline systolic blood pressure on long-term outcomes in patients with advanced chronic systolic heart failure (insights from the BEST trial). Am J Cardiol. 2010;106(2):221–7.
PubMed
Article
Google Scholar
Norris K, Bourgoigne J, Gassman J, Hebert L, et al. Cardiovascular outcomes in the African American Study of Kidney Disease and Hypertension AASK (Trial). Am J Kidney Dis. 2006;48:739–51.
PubMed
Article
CAS
Google Scholar
Lewis EJ, Hunsicker LG, Clarke WR, et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med. 2001;345:851–60.
PubMed
Article
CAS
Google Scholar
Aronow WS. What should the optimal blood pressure goal be in patients with diabetes mellitus or chronic kidney disease? Arch Med Sci. 2012;8:399–402.
PubMed
Article
Google Scholar
Agarwal R. Blood pressure components and the risk for end-stage renal disease and death in chronic kidney disease. Clin J Am Soc Nephrol. 2009;4(4):830–7.
PubMed
Article
Google Scholar
Piotrowski G, Banach M, Gerdts E, Mikhailidis DP, Hannam S, Gawor R, Stasiak A, Rysz J, Gawor Z. Left atrial size in hypertension and stroke. J Hypertens. 2011;29:1988–93.
PubMed
Article
CAS
Google Scholar
Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ. 2009;338:1665–83.
Article
Google Scholar
• Optimal Blood Pressure and Cholesterol Targets for Preventing Recurrent Stroke in Hypertensives (ESH-CHL-SHOT). ClinicalTrials.gov Identifier: NCT01563731. The first study that aimed to investigate the optimal blood pressure levels in patients after stroke/TIA (as well as the J-shaped relationship in this group of patients).
Zanchetti A. Blood pressure targets of antihypertensive treatment: up and down the J-shaped curve. Eur Heart J. 2010;31:2837–40.
PubMed
Article
CAS
Google Scholar
Athyros VG, Hatzitolios AI, Karagiannis A, Savopoulos C, Katsiki N, Tziomalos K, Papagianni A, Kakafika A, Gossios TD, Mikhailidis DP, IMPERATIVE Collaborative Group. IMproving the imPlemEntation of cuRrent guidelines for the mAnagement of major coronary hearT disease rIsk factors by multifactorial interVEntion. The IMPERATIVE renal analysis. Arch Med Sci. 2011;7(6):984–92.
PubMed
Article
CAS
Google Scholar
Systolic Blood Pressure Intervention Trial (SPRINT). ClinicalTrials.gov Identifier: NCT01206062.
Sethi A, Arora RR. Ambulatory blood pressure as a predictor of cardiovascular risk. Arch Med Sci. 2009;5:3–9.
Google Scholar
Stepien M, Banach M, Jankowski P, Rysz J. Clinical implications of non-invasive measurement of central aortic blood pressure. Curr Vasc Pharmacol. 2010;8:747–52.
PubMed
Article
CAS
Google Scholar
Lai HM, Aronow WS, Mercando AD, Kalen P, Desai HV, Gandhi K, Sharma M, Amin H, Lai TM. Risk factor reduction in progression of angiographic coronary artery disease. Arch Med Sci. 2012;8(3):444–8.
PubMed
Article
Google Scholar
Zanchetti A, Mancia G, Black HR, Oparil S, Waeber B, Schmieder RE, Bakris GL, Messerli FH, Kjeldsen SE, Ruilope LM. Facts and fallacies of blood pressure control in recent trials: implications in the management of patients with hypertension. J Hypertens. 2009;27:673–9.
PubMed
Article
CAS
Google Scholar